Market Research Logo

Taiwan Pharmaceuticals & Healthcare Q4 2018

Taiwan Pharmaceuticals & Healthcare Q4 2018

Key View :

Taiwan’s healthcare environment continues to evolve, as it also intensifies international exchanges and cooperation indrug supervision to support the application of new medicines. Inclusion of Taiwan’s Food and Drug Administration (TFDA) in theInternational Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) will form a part of abroader reform as authorities seek to shape opportunities for multinational drugmakers.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Asia Pacific Innovative Pharmaceuticals & Healthcare Risk/Reward Index
Taiwan Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Sanofi
GlaxoSmithKline
Merck & Co
Novartis
Pfizer
ScinoPharm Taiwan
TaiGen
Yung Shin Pharmaceutical
Taiwan Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report